Chemotheraphy Induced Nausea and Vomitting Drugs Market

The global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market was valued at 2323.34 Million USD in 2021 and will grow with a CAGR of 1.64% from 2021 to 2027, based on Research newly published report.

The prime objective of Chemotheraphy Induced Nausea and Vomitting Drugs Market is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, Chemotheraphy Induced Nausea and Vomitting Drugs Market covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).

Chemotherapy-induced nausea and vomiting (CINV) is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families. In 1983, Coates et al. found that patients receiving chemotherapy ranked nausea and vomiting as the first and second most severe side effects, respectively. Up to 20% of patients receiving highly emetogenic agents in this era postponed, or even refused, potentially curative treatments. Since the 1990s, several novel classes of antiemetics have been developed and commercialized, becoming a nearly universal standard in chemotherapy regimens, and helping to better manage these symptoms in a large portion of patients. Efficient mediation of these unpleasant and sometimes crippling symptoms results in increased quality of life for the patient, and better overall health of the patient, and, due to better patient tolerance, more effective treatment cycles.Affecting 70-80% of patients undergoing chemotherapy, chemotherapy-induced nausea and vomiting (CINV) is one of chemotherapy`s most debilitating side effects, often attributed as a leading cause of premature discontinuation of cancer treatment. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs key players include Haisco, Merck, Mundipharma, Qilu Pharma, Heron Therapeutics, Teva, etc. Global top six manufacturers hold a share about 30%. North America is the largest market, with a share about 35%, followed by Europe and Asia-Pacific, both have a share about 60 percent. In terms of product, 5-HT3 Inhibitors is the largest segment, with a share over 70%. And in terms of application, the largest application is Acute CINV, followed by Delayed CINV and Breakthrough CINV.

By Market Verdors:

• Heron Therapeutics
• Merck
• Eisai
• Mundipharma
• Qilu Pharma
• Teva
• Novartis
• Roche
• Mylan
• Baxter
• GSK
• Helsinn
• Southwest Pharma
• Haisco
• Sun Pharma

By Types:

• 5-HT3 Inhibitors
• NK1 Inhibitors

By Applications:

• Acute CINV
• Delayed CINV
• Breakthrough CINV

Key Indicators Analysed

• Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the markets competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
• Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
• Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
• Opportunities and Drivers: Identifying the Growing Demands and New Technology
• Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Key Reasons to Purchase

• To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
• Assess the production processes, major issues, and solutions to mitigate the development risk.
• To understand the most affecting driving and restraining forces in the market and its impact in the global market.
• Learn about the market strategies that are being adopted by leading respective organizations.
• To understand the future outlook and prospects for the market.
• Besides the standard structure reports, we also provide custom research according to specific requirements.